share_log

Independent Director Of Tenet Healthcare Sold 49% Of Their Shares

Independent Director Of Tenet Healthcare Sold 49% Of Their Shares

Tenet Healthcare獨立董事出售了49%的股份
Simply Wall St ·  2023/11/26 07:32

We'd be surprised if Tenet Healthcare Corporation (NYSE:THC) shareholders haven't noticed that the Independent Director, Richard Fisher, recently sold US$400k worth of stock at US$66.65 per share. The eyebrow raising move amounted to a reduction of 49% in their holding.

如果Tenet Healthcare Corporation(紐約證券交易所代碼:THC)的股東沒有注意到獨立董事理查德·費舍爾最近以每股66.65美元的價格出售了價值40萬美元的股票,我們會感到驚訝。令人驚訝的舉動使他們的持股量減少了49%。

Check out our latest analysis for Tenet Healthcare

查看我們對 Tenet Healthcare 的最新分析

Tenet Healthcare Insider Transactions Over The Last Year

去年 Tenet Healthcare 的內幕交易

In the last twelve months, the biggest single sale by an insider was when the EVP, Chief Administrative Officer, Thomas Arnst, sold US$1.5m worth of shares at a price of US$73.80 per share. So what is clear is that an insider saw fit to sell at around the current price of US$68.00. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).

在過去的十二個月中,內部人士最大的一次出售是執行副總裁兼首席行政官托馬斯·阿恩斯特以每股73.80美元的價格出售了價值150萬美元的股票。因此,顯而易見的是,一位內部人士認爲以當前的68.00美元左右的價格賣出是合適的。我們通常不喜歡看到內幕銷售,但是銷售價格越低,我們就越擔心。在這種情況下,大甩賣是在當前價格左右進行的,因此還不錯(但仍然不是積極的)。

In the last year Tenet Healthcare insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

去年,Tenet Healthcare內部人士沒有購買任何公司股票。下圖顯示了去年的內幕交易(公司和個人)。通過點擊下面的圖表,你可以看到每筆內幕交易的確切細節!

insider-trading-volume
NYSE:THC Insider Trading Volume November 26th 2023
紐約證券交易所:THC 內幕交易量 2023 年 11 月 26 日

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

如果你像我一樣,那麼你不會想錯過這份業內人士正在收購的成長型公司的免費名單。

Insider Ownership

內部所有權

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Tenet Healthcare insiders own about US$109m worth of shares (which is 1.6% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

我喜歡看看內部人士在一家公司擁有多少股票,以幫助我了解他們與內部人士的看法。較高的內部所有權通常會使公司領導層更加關注股東的利益。Tenet Healthcare內部人士擁有價值約1.09億美元的股份(佔該公司的1.6%)。大多數股東會很高興看到這種內部所有權,因爲這表明管理層的激勵措施與其他股東非常一致。

So What Do The Tenet Healthcare Insider Transactions Indicate?

那麼 Tenet Healthcare 內幕交易表明了什麼?

An insider sold Tenet Healthcare shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. It is good to see high insider ownership, but the insider selling leaves us cautious. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Case in point: We've spotted 3 warning signs for Tenet Healthcare you should be aware of, and 1 of them doesn't sit too well with us.

一位內部人士最近出售了Tenet Healthcare的股票,但他們沒有購買任何股票。展望過去的十二個月,我們的數據並未顯示任何內幕買盤。看到較高的內部所有權是件好事,但內幕拋售使我們持謹慎態度。因此,這些內幕交易可以幫助我們建立有關股票的論點,但也值得了解這家公司面臨的風險。一個很好的例子:我們發現了你應該注意的Tenet Healthcare的3個警告信號,其中一個對我們來說不太合適。

Of course Tenet Healthcare may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,Tenet Healthcare可能不是最好的買入股票。因此,您可能希望看到這個免費的高質量公司集合。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是那些向相關監管機構報告交易的個人。我們目前僅對公開市場交易和直接權益的私人處置進行覈算,但不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論